End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.85 NZD | 0.00% | +4.78% | -18.57% |
May. 01 | AFT Pharmaceuticals Signs Brazil Licensing Agreement for Maxigesic IV | MT |
Apr. 24 | New Zealand Shares Rise on US Earnings Rally; AFT Pharmaceuticals to Develop Topical Scar Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.57% | 183M | |
+34.35% | 705B | |
+29.39% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+14.11% | 238B | |
-3.03% | 210B | |
+10.02% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- AFT Stock
- News AFT Pharmaceuticals Limited
- Transcript : AFT Pharmaceuticals Limited, H1 2021 Earnings Call, Nov 19, 2020